Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
March 9, 2026
EUROPE – Revision of the EU General Pharmaceutical Legislation – Regulatory Protections
February 9, 2026
FTC’s “Landmark” Settlement with Pharmacy Benefit Manager Express Scripts: Impact on Pharma
March 5, 2026
SEC Senior Trial Attorney Emmett Murphy Rejoins King & Spalding in New York
March 5, 2026
Sage Completes $65 Million Series C Financing
February 27, 2026
Appeals Court Rejects Kaiser Health Plan’s Attempt to Throw Out $105 Million Judgment
January 27, 2026
King & Spalding Secures Significant Success for R.J. Reynolds